This study investigates pancreatic cancer. It looks at how a combination of chemotherapy drugs and radiation therapy, given before surgery, might help in treating this condition.
The study evaluates the safety and effectiveness of these treatments when used together before surgery. It checks how well the treatments work and their impact on patients' health outcomes.
- Who can participate: Adults 18 years or older with localized, potentially resectable pancreatic adenocarcinoma can participate. They must have a good performance status and adequate organ function. Prior therapy for pancreatic cancer is not allowed.
- Study details: Participants will receive chemotherapy and radiation therapy before surgery. A placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine, is not used in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand